Classification of pancreatic cancer (nonendocrine)
- PMID: 221755
Classification of pancreatic cancer (nonendocrine)
Abstract
From the records of 757 patients listed as having had pancreatic cancer at Memorial Hospital during the years 1949 through 1972, adequate clinical data and pathologic tissue were available for study in 508 patients. Review of these cases led to a histologic classification into 11 subcategories and one unclassified group. The most common type was the duct cell adenocarcinoma (75%), and the remaining subgroups each made up less than 5% of the total. All except one of the subtypes were well-known carcinoma patterns that occur in other organs. A small-gland carcinoma, the microadenocarcinoma, has not usually been associated with the pancreas. Some types were associated with short survival periods of a few months after diagnosis--for example, duct cell, giant cell, acinar cell, and adenosquamous carcinomas and microadenocarcinoma. Patients with mucinous carcinoma had a mean survival period of a few months longer, and the few patients with mucinous cystadenocarcinoma had a much longer median survival. Two rare types--papillary cystic tumor and pancreaticoblastoma--are mentioned and illustrated. It is hoped that one or more of these types can be associated with an etiologic agent, some clinical feature, or responsiveness to a therapeutic regimen.
Similar articles
-
Morphological patterns of primary nonendocrine human pancreas carcinoma.Cancer Res. 1975 Aug;35(8):2234-48. Cancer Res. 1975. PMID: 167949
-
Morphological study of 391 cases of exocrine pancreatic tumours with special reference to the classification of exocrine pancreatic carcinoma.J Pathol. 1985 May;146(1):17-29. doi: 10.1002/path.1711460103. J Pathol. 1985. PMID: 2989468
-
Cancer of the pancreas (nonendocrine): a suggested morphologic classification.Semin Oncol. 1979 Sep;6(3):285-97. Semin Oncol. 1979. PMID: 228430 No abstract available.
-
Pancreatic cystic tumours: when to resect, when to observe.Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):395-406. Eur Rev Med Pharmacol Sci. 2010. PMID: 20496554 Review.
-
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma.Pancreatology. 2009;9(1-2):25-33. doi: 10.1159/000178872. Epub 2008 Dec 12. Pancreatology. 2009. PMID: 19077452 Review.
Cited by
-
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.Ann Surg. 1998 Jul;228(1):79-86. doi: 10.1097/00000658-199807000-00012. Ann Surg. 1998. PMID: 9671070 Free PMC article.
-
Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.Mol Carcinog. 2014 Sep;53(9):711-21. doi: 10.1002/mc.22023. Epub 2013 May 9. Mol Carcinog. 2014. PMID: 23661430 Free PMC article.
-
Pancreatoblastoma: a histochemical and immunohistochemical analysis.J Clin Pathol. 1996 Nov;49(11):952-4. doi: 10.1136/jcp.49.11.952. J Clin Pathol. 1996. PMID: 8944621 Free PMC article. Review.
-
Pancreaticoduodenectomy for pancreatoblastoma: a case report and literature review.Pediatr Surg Int. 2010 Apr;26(4):447-50. doi: 10.1007/s00383-010-2561-1. Epub 2010 Feb 18. Pediatr Surg Int. 2010. PMID: 20165952 Review.
-
Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.J Gastrointest Surg. 2008 Jun;12(6):1061-7. doi: 10.1007/s11605-007-0338-1. Epub 2007 Oct 24. J Gastrointest Surg. 2008. PMID: 17957440